1. Home
  2. FOLD vs LRN Comparison

FOLD vs LRN Comparison

Compare FOLD & LRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.30

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Logo Stride Inc.

LRN

Stride Inc.

HOLD

Current Price

$87.83

Market Cap

3.6B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOLD
LRN
Founded
2002
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
3.6B
IPO Year
2007
2007

Fundamental Metrics

Financial Performance
Metric
FOLD
LRN
Price
$14.30
$87.83
Analyst Decision
Buy
Buy
Analyst Count
10
4
Target Price
$26.11
$106.75
AVG Volume (30 Days)
7.8M
1.7M
Earning Date
02-18-2026
01-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
9.29
EPS
N/A
6.50
Revenue
$598,704,000.00
$2,519,167,000.00
Revenue This Year
$21.49
$5.47
Revenue Next Year
$18.46
$4.81
P/E Ratio
N/A
$13.30
Revenue Growth
21.28
14.86
52 Week Low
$5.51
$60.62
52 Week High
$14.38
$171.17

Technical Indicators

Market Signals
Indicator
FOLD
LRN
Relative Strength Index (RSI) 79.26 81.02
Support Level $14.30 $82.92
Resistance Level $14.31 $89.17
Average True Range (ATR) 0.03 3.59
MACD -0.13 1.38
Stochastic Oscillator 35.00 83.01

Price Performance

Historical Comparison
FOLD
LRN

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

About LRN Stride Inc.

Stride Inc is an American online educational company. It offers alternative programs to traditional on-campus schooling. It also operates state-funded virtual charter schools around the United States. The educational programs for K-12 students are usually monitored by parents and provide virtual classroom environments where teachers meet with students online, by phone, or in-person. The company's contractual agreements with various school districts to offer its curriculum programs provide a majority of the company's revenue. The company lines of business are Managed Public School Programs, Institutional and Private Pay Schools and Other.

Share on Social Networks: